FindTrial
Sign In

Efficacy of Aasthapan Basti and Nasya in Polycystic ovarian syndrome

A comparative study to evaluate the effect of Aasthapan Basti and Nasya in the management of Polycystic ovarian syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/032886
Enrollment
20
Registered
2021-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Aasthapan Basti: Palash Basti in kaal basti krama Control Intervention1: Nasya: Snehana Nasya with Narayan tail 10 drops per nostril for 16 days

Sponsors

Principal RGGPG Ayurvedic college and hospital paprola
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient willing to go through trial. 2. Affected individuals presented with two out of three criteria of ASHRM/ESHRE (ROTTERDAM) CRITERIA 2013. 3. Clinically diagonosed and confirmed patients of PCOS.

Exclusion criteria

Exclusion criteria: 1. Women of age less than 16 and above 35 years. 2. Patient having systemic diseases like hypertension, tuberculosis, renal disease, thyroid disorders associated gynecological disorders. 3. Patient having congenital adrenal hyperplasia, androgen secreting tumours.

Design outcomes

Primary

MeasureTime frame
Fulfillment of objective and subjective criteriaTimepoint: Three months—

Secondary

MeasureTime frame
General feeling of well beingTimepoint: Three months—

Countries

India

Contacts

Public ContactDr Pooja Kaushik

Rajiv Gandhi government post graduate ayurvedic college and hospital paprola

anil5karma@gmail.com9418466766

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026